Oncology Care in a Value-Based World

The shift from fee-for-service to value-based care has been undeniably gaining momentum over the past few years. However, 2020 brought an incredible influx of factors that were not previously accounted for. Join our Precision Value & Health colleagues Stephanie Kennedy of PRECISIONadvisors, Janet Serluco of PRECISIONvalue, and Matt Pitzel of PRECISIONxtract, on Wednesday, May 19 at 1:00 PM ET, for this collaborative webinar exploring the results of our proprietary survey on the challenges and opportunities facing value-based oncology care.

The Future of Reimbursement for Cell and Gene Therapies

Join us Tuesday, June 22, at 4:00 PM ET for The Future of Reimbursement for Cell and Gene Therapies, where payer representatives from the UK and Germany and an industry representative will discuss how payers will respond to the changing cell and gene therapies landscape, and how manufacturers can proactively mitigate their strategies. Moderated by PRECISIONadvisor’s Richard Macaulay, this unique webinar will expand the discussion of cell and gene therapies as presented by Richard at World EPA Congress.

Methodological Borrowing versus Conceptual Blending: Reengineering Health Economics Processes with Modeling and Simulations

In general, health decision modeling methods widely evaluate the role of drug technology or intervention, from its impact on patient’s quality of life, to consequences on societal and healthcare economics. Moderated by Ross Maclean, join Anuj Mubayi on Wednesday, June 30 at 1:00 PM ET, as we discuss the main challenges confronting modeling approaches and analysis, and how the COVID-19 pandemic has shifted the global discussion on health decision analysis tools for new coronavirus-related health problems.